Cargando…

Association Study of KCNH7 Polymorphisms and Individual Responses to Risperidone Treatment in Schizophrenia

Risperidone has been used to treat the symptoms of schizophrenia and to reduce its relapse. However, the responses to treatment show great variability among patients. The potassium channel has been reported as an effective target for antipsychotics. KCNH7, a member of the voltage-gated K(+) channel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xueping, Su, Yi, Yan, Hao, Huang, Zhuo, Huang, Yu, Yue, Weihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728906/ https://www.ncbi.nlm.nih.gov/pubmed/31543842 http://dx.doi.org/10.3389/fpsyt.2019.00633

Ejemplares similares

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
por: Liao, Jingping, et al.
Publicado: (2020)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
por: Aquino, Adriano, et al.
Publicado: (2018)

Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
por: Qiu, Yuying, et al.
Publicado: (2023)

Striatum-related spontaneous coactivation patterns predict treatment response on positive symptoms of drug-naive first-episode schizophrenia with risperidone monotherapy
por: Zong, Xiaofen, et al.
Publicado: (2023)

Influence of EGR3 Transfection on Imaging and Behavior in Rats and Therapeutic Effect of Risperidone in Schizophrenia Model
por: Li, Guangfei, et al.
Publicado: (2020)

Risperidone Effects on Brain Dynamic Connectivity—A Prospective Resting-State fMRI Study in Schizophrenia
por: Lottman, Kristin K., et al.
Publicado: (2017)

Risperidone-Associated Neuroleptic Malignant Syndrome in an Inpatient With Schizophrenia, With Successful Rechallenge and 3 Year Follow-Up
por: Chen, Ting-Ren, et al.
Publicado: (2018)

Association of MTHFR C677T Polymorphism With Antipsychotic-Induced Change of Weight and Metabolism Index
por: Su, Yi, et al.
Publicado: (2021)

Deciphering Risperidone-Induced Lipogenesis by Network Pharmacology and Molecular Validation
por: Fu, Yun, et al.
Publicado: (2022)

S186. KCNH2 POLYMORPHISM ASSOCIATED TO ALTERED EEG FUNCTIONAL NETWORK MODULATION IN SCHIZOPHRENIA
por: Juárez, Alba Lubeiro, et al.
Publicado: (2018)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Risperidone-Induced Sexual Dysfunction Case Report
por: Cichon, Gregory J, et al.
Publicado: (2023)

Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies
por: Stojkovic, Milena, et al.
Publicado: (2022)

Pathophysiology and management of risperidone-induced sialorrhea: case report
por: Torrico, Tyler, et al.
Publicado: (2023)

Common and Distinct Alterations of Cognitive Function and Brain Structure in Schizophrenia and Major Depressive Disorder: A Pilot Study
por: Ma, Mengying, et al.
Publicado: (2021)

Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia
por: Pelegrino, Ana, et al.
Publicado: (2023)

Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients
por: Wang, Gang, et al.
Publicado: (2020)

Markers of muscarinic deficit for individualized treatment in schizophrenia
por: Stuke, Heiner
Publicado: (2023)

Risperidone-induced Somnambulism: A Case Report and Brief Review of Literature
por: Najmi, Ahmad, et al.
Publicado: (2020)

Understanding MMPI-2 response structure between schizophrenia and healthy individuals
por: Hsu, Yu Cheng, et al.
Publicado: (2022)

Association of Serotonin(2c) Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia
por: Li, Jiang, et al.
Publicado: (2019)

Chemosensory Anhedonia in Patients With Schizophrenia and Individuals With Schizotypy: A Questionnaire Study
por: Li, Zi-lin, et al.
Publicado: (2020)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

The Deficits of Individual Morphological Covariance Network Architecture in Schizophrenia Patients With and Without Violence
por: Shen, Danlin, et al.
Publicado: (2021)

Association Study of MTHFR C677T Polymorphism and Birth Body Mass With Risk of Autism in Chinese Han Population
por: Zhang, Jishui, et al.
Publicado: (2021)

The Effects of Risperidone on Cognition in People With Autism Spectrum Disorder: A Systematic Review
por: Hutchinson, Jhenelle, et al.
Publicado: (2023)

Longitudinal multi-omics alterations response to 8-week risperidone monotherapy: Evidence linking cortical thickness, transcriptomics and epigenetics
por: Zong, Xiaofen, et al.
Publicado: (2023)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Duggal, Harpreet S., et al.
Publicado: (1999)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998)

Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia
por: Liang, Wei, et al.
Publicado: (2020)

Risperidone for the Management of Treatment-Resistant Anxiety in a Patient with Ehlers-Danlos Syndrome: A Case Report
por: Niedt, Katherine, et al.
Publicado: (2020)

Altered Resting-State Brain Activity in Schizophrenia and Obsessive-Compulsive Disorder Compared With Non-psychiatric Controls: Commonalities and Distinctions Across Disorders
por: Zhang, Yuyanan, et al.
Publicado: (2021)

A Machine Learning Model to Predict Risperidone Active Moiety Concentration Based on Initial Therapeutic Drug Monitoring
por: Guo, Wei, et al.
Publicado: (2021)

Methylome-wide association study of different responses to risperidone in schizophrenia
por: Du, Huihui, et al.
Publicado: (2022)

Effect of Aerobic Exercise on Improving Symptoms of Individuals With Schizophrenia: A Single Blinded Randomized Control Study
por: Wang, Peng-Wei, et al.
Publicado: (2018)

Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations
por: Zhang, Xianqin, et al.
Publicado: (2008)

Understanding and Managing Cognitive Distortions in Individuals With Schizophrenia
por: Verma, Kamal K
Publicado: (2023)

Association between polymorphisms in NOS3 and KCNH2 and social memory
por: Henningsson, Susanne, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_va3enn7hk95fhn1aecn14ad6g3